December 2013 - 22 (130)

A paradigm shift in pulmonary arterial hypertension management Rubin Lewis J., Galiè Nazzareno, Simonneau Gérald, McLaughlin Vallerie Eur Respir Rev 2013; 22: 423-426
Lymphoproliferative lung disorders: clinicopathological aspects Poletti Venerino, Ravaglia Claudia, Tomassetti Sara, Gurioli Carlo, Casoni Gianluca, Asioli Silvia, Dubini Alessandra, Piciucchi Sara, Chilosi Marco Eur Respir Rev 2013; 22: 427-436
Respiratory manifestations in patients with inherited metabolic diseases Santamaria Francesca, Montella Silvia, Mirra Virginia, De Stefano Sara, Andria Generoso, Parenti Giancarlo Eur Respir Rev 2013; 22: 437-453
Comorbidities of COPD Cavaillès Arnaud, Brinchault-Rabin Graziella, Dixmier Adrien, Goupil François, Gut-Gobert Christophe, Marchand-Adam Sylvain, Meurice Jean-Claude, Morel Hugues, Person-Tacnet Christine, Leroyer Christophe, Diot Patrice Eur Respir Rev 2013; 22: 454-475
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis Uttley Lesley, Harnan Sue, Cantrell Anna, Taylor Chris, Walshaw Martin, Brownlee Keith, Tappenden Paul Eur Respir Rev 2013; 22: 476-486
The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension Gaine Sean, Simonneau Gérald Eur Respir Rev 2013; 22: 487-494
New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension Preston Ioana R., Suissa Samy, Humbert Marc Eur Respir Rev 2013; 22: 495-502
New horizons in pulmonary arterial hypertension therapies Galiè Nazzareno, Ghofrani Ardeschir-Hossein Eur Respir Rev 2013; 22: 503-514
Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations Schwaiger Johannes P., Khanna Dinesh, Gerry Coghlan J. Eur Respir Rev 2013; 22: 515-525
Cardiac magnetic resonance imaging in pulmonary arterial hypertension Peacock Andrew J., Vonk Noordegraaf Anton Eur Respir Rev 2013; 22: 526-534
Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives Guillevin Loïc, Armstrong Iain, Aldrighetti Rino, Howard Luke S., Ryftenius Henrik, Fischer Aryeh, Lombardi Sandra, Studer Sean, Ferrari Pisana Eur Respir Rev 2013; 22: 535-542
Pathogenesis of pulmonary arterial hypertension: lessons from cancer Guignabert Christophe, Tu Ly, Le Hiress Morane, Ricard Nicolas, Sattler Caroline, Seferian Andrei, Huertas Alice, Humbert Marc, Montani David Eur Respir Rev 2013; 22: 543-551
Fibrocytes in pulmonary fibrosis: a brief synopsis Maharaj Shyam, Shimbori Chiko, Kolb Martin Eur Respir Rev 2013; 22: 552-557
Eisenmenger syndrome in an adult patient with a large patent ductus arteriosus Dimopoulos Konstantinos Eur Respir Rev 2013; 22: 558-564
Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy Bergot Emmanuel, Levallet Guénaëlle, Campbell Karine, Dubois Fatéméh, Lechapt Emmanuèle, Zalcman Gérard Eur Respir Rev 2013; 22: 565-576
How to adapt the pulmonary rehabilitation programme to patients with chronic respiratory disease other than COPD Holland Anne E., Wadell Karin, Spruit Martijn A. Eur Respir Rev 2013; 22: 577-586
Rituximab-induced pneumonitis mimicking miliary tuberculosis Yao Chih-Wei, Liao Wei-Chih, Tu Chih-Yen, Chen Hung-Jen, Teseng Guan-Chin, Yeh Su-Peng Eur Respir Rev 2013; 22: 587-588
“Serious bronchopulmonary involvement due to chronic lymphocytic leukaemia.” Delphine Carmier Catherine Dartigeas Julie Mankikian Cecilla Rousselot-Denis Severine Lissandre Patrice Diot, Sylvain Marchand-Adam. Eur Respir Rev 2013; 22: 416–419. Author Correction Eur Respir Rev 2013; 22: 589
Book Review Bourdin A. Eur Respir Rev 2013; 22: 590
Book Review Vachiery J-L. Eur Respir Rev 2013; 22: 591